ACADIAN ASSET MANAGEMENT LLC

Position in AUTL — Autolus Therapeutics plc

CIK 916542 Boston, MA

Position in AUTL

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$45,006

+$6,923 QoQ

Shares Held

28,129

+1.9% QoQ

Ownership

0.011%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#47

of 84 holders

Holding Since

Jun 2020

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

ACADIAN ASSET MANAGEMENT LLC holds $731,256,203 across 167 Biotechnology names. AUTL ranks #153 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INCY	Incyte Corp	1,664,999	$188,744,286
2	REGN	Regeneron Pharmaceuticals, Inc.	157,440	$98,170,137
3	IMCR	Immunocore Holdings plc	1,209,894	$38,414,134
4	RIGL	Rigel Pharmaceuticals Inc	591,686	$23,146,756
5	EXEL	Exelixis, Inc.	421,444	$22,930,768
6	VRTX	Vertex Pharmaceuticals Inc / Ma	42,122	$20,923,261
7	TBPH	Theravance Biopharma, Inc.	1,174,910	$19,973,470
8	PRTA	Prothena Corp Public Ltd Co	2,010,645	$19,684,214

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$45,006	28,129	+1.9%	Shares	Defined	2026-08-13
2026-03-31	$38,083	27,597	-98.5%	Shares	Defined	2026-05-13
2025-12-31	$3,590,192	1,804,117	-2.7%	Shares	Defined	2026-02-10
2025-09-30	$3,021,077	1,853,422	+3193.6%	Shares	Defined	2025-11-13
2024-12-31	$132,241	56,273	+361.6%	Shares	Defined	2025-02-11
2023-03-31	$22,433	12,192	-44.6%	Shares	Defined	2023-05-11
2022-12-31	$41,847	22,025	-36.9%	Shares	Defined	2023-02-14
2022-06-30	$98,733	34,888	+11.5%	Shares	Defined	2022-08-09
2021-09-30	$204,942	31,289	+1417.4%	Shares	Defined	2021-11-12
2020-09-30	$24,001	2,062	-52.0%	Shares	Defined	2020-11-09
2020-06-30	$68,848	4,295	—	Shares	Defined	2020-08-12
No filing history on record for this holder in this stock.